ATRS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 05:30):

Stats
आज की मात्रा	1.76M
औसत मात्रा	5.23M
बाजार मूल्य	0.00
EPS	$-0.0100 ( 2022-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	14.95
ATR14	$0.104 (1.86%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-24	Gueth Anton	Sell	79 645	Common Stock
2022-05-24	Gueth Anton	Sell	61 930	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	99 395	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	150 000	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	80 318	Stock Option (right to buy)

INSIDER POWER
-100.00
Last 97 transactions
Buy: 1 667 582 \| Sell: 3 999 780

मात्रा सहसंबंध

लंबा: 0.33 (neutral)

छोटा: 0.37 (neutral)

Signal:(78.671) Neutral

Antares Pharma Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
SJ	0.968
SERA	0.963
THCPU	0.962
SEAC	0.958
PEGA	0.954
HSKA	0.951
MLTX	0.951
GXII	0.948
KIN	0.947
ISRG	0.946

10 सबसे अधिक नकारात्मक सहसंबंध
CHDN	-0.971
CFBK	-0.968
HURC	-0.965
PEAR	-0.951
AGIL	-0.951
GRNA	-0.95
VRAY	-0.948
PROC	-0.947
SNGX	-0.946
VWE	-0.942

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Antares Pharma Inc सहसंबंध - मुद्रा/वस्त्र

-0.58
( weak negative )

-0.73
( moderate negative )

0.00
( neutral )

-0.80
( moderate negative )

-0.28
( neutral )

0.68
( moderate )

Antares Pharma Inc वित्तीय

Annual	2021
राजस्व:	$183.98M
सकल लाभ:	$115.70M (62.89 %)
EPS:	$0.280

FY	2021
राजस्व:	$183.98M
सकल लाभ:	$115.70M (62.89 %)
EPS:	$0.280

FY	2020
राजस्व:	$149.60M
सकल लाभ:	$86.50M (57.82 %)
EPS:	$0.340

FY	2019
राजस्व:	$123.86M
सकल लाभ:	$73.39M (59.25 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

Antares Pharma Inc

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.